If the number of cards in your opponent's hand is at least 6, look at his or her hand. Choose a number of cards there until your opponent has 5 cards left in his or her hand and have your opponent shuffle the cards you chose into his or her deck.
Count the amount of Energy attached to all of your Pokémon and all of your opponent's Pokémon. If your Pokémon have less Energy than your opponent's, this attack does 20 damage plus 30 more damage.
Dragon was released in 2003. It belongs to the EX series.
Set size is 100 cards, which categorizes Dragon as mid-size. As of 2026, the set is 23 years old and fits a legacy-era profile.
In the Dragon checklist, Skarmory occupies position #21 as a Rare card.
Skarmory appears in Dragon, released in 2003. Its card type is Pokémon.
The rarity label is Rare. Printed HP is 70.
Energy typing is Metal. This gives collectors a clear identity footprint for the print.
This print is categorized under the Basic subtype. Notable move text references "Pick On" and "Power Count".
Current market pricing for Skarmory (Dragon) sits near $1.89. Week-over-week change is limited (0.0%), indicating short-term stability.
Current pricing is broadly aligned with its 30-day average ($1.89). Its 90-day trading band runs between $1.62 and $1.93, producing a 16% range and low-volatility behavior.
The listed rarity for this print is Rare.
Skarmory sits within a broader pool of Skarmory variants that can be compared by set, rarity, and price. Comparable entries in this snapshot: 6 cards, 5 distinct sets.
In this sample, pricing ranges between $0.06 and $7.44 (12300% total span). Relative to the alternative average ($1.37), this card is +38%.
Notable alternatives include Skarmory #69 (Roaring Skies) at $0.27, Skarmory #59 (Phantom Forces) at $0.21, Skarmory #182 (Fusion Strike) at $0.06, and Skarmory #120 (Darkness Ablaze) at $0.14.
Market structure summary: Weekly drift is minimal (0.0%), indicating a relatively balanced short-term market. With a 16% 90-day spread ($1.62-$1.93), this card currently tracks as low-volatility.
Relative to the 30-day baseline ($1.89), pricing is near equilibrium. Graded context points to a substantial premium curve, with PSA 10 at +3194% above raw pricing.
PSA 9 is currently around $17.00, while PSA 10 is $62.25.
